Bayer, CRISPR form gene editing JV to cure blood disorders, blindness, and congenital heart disease
- Gene Therapy, Cell Therapy
- Large Molecule
- Drug Delivery
- Joint Venture
- R+D and Marketing-Licensing
- Includes Equity
- Product or Technology Swap
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.